Perfect Medical Industry Co., Ltd. (TPEX:6543)
Taiwan · Delayed Price · Currency is TWD 20.95
-0.20 (-0.95%)
May 29, 2026, 12:13 PM CST
Perfect Medical Industry Income Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 779.02 | 744.16 | 734.13 | 677.04 | 724.61 | |
Revenue Growth (YoY) | 4.68% | 1.36% | 8.43% | -6.57% | -10.29% |
Cost of Revenue | 578.25 | 505.96 | 533.58 | 542.63 | 515.08 |
Gross Profit | 200.76 | 238.19 | 200.56 | 134.41 | 209.53 |
Selling, General & Admin | 133.61 | 135.78 | 134.78 | 123.61 | 145.44 |
Research & Development | 15.83 | 11.09 | 7.4 | 7.12 | 5.58 |
Operating Expenses | 149.35 | 146.95 | 142.2 | 130.75 | 151.28 |
Operating Income | 51.42 | 91.24 | 58.36 | 3.65 | 58.24 |
Interest Expense | -6.83 | -3.72 | -4.37 | -4.46 | -2.96 |
Interest & Investment Income | 5.95 | 5.42 | 3.33 | 1.03 | 1.6 |
Currency Exchange Gain (Loss) | 13.12 | 13.42 | 7.34 | 13.18 | 3.93 |
Other Non Operating Income (Expenses) | 7.82 | 4.9 | 3.02 | 3.33 | 1.52 |
EBT Excluding Unusual Items | 71.47 | 111.26 | 67.67 | 16.73 | 62.33 |
Gain (Loss) on Sale of Assets | -0.02 | 0.4 | 1.19 | 1.18 | 0.19 |
Asset Writedown | - | -4.28 | -14.61 | - | - |
Other Unusual Items | 0.08 | - | - | 0.06 | - |
Pretax Income | 71.53 | 107.38 | 54.25 | 17.98 | 62.52 |
Income Tax Expense | 17.29 | 18.26 | 14.16 | 3.71 | 23.75 |
Net Income | 54.25 | 89.12 | 40.09 | 14.27 | 38.77 |
Net Income to Common | 54.25 | 89.12 | 40.09 | 14.27 | 38.77 |
Net Income Growth | -39.13% | 122.31% | 180.93% | -63.20% | -61.49% |
Shares Outstanding (Basic) | 54 | 49 | 46 | 44 | 41 |
Shares Outstanding (Diluted) | 57 | 51 | 46 | 44 | 41 |
Shares Change (YoY) | 12.08% | 11.20% | 3.98% | 8.91% | -2.73% |
EPS (Basic) | 1.00 | 1.81 | 0.88 | 0.32 | 0.95 |
EPS (Diluted) | 0.95 | 1.74 | 0.87 | 0.32 | 0.95 |
EPS Growth | -45.40% | 100.00% | 171.88% | -66.32% | -60.44% |
Free Cash Flow | -88.46 | 46.56 | 85.17 | 52.87 | -98.89 |
Free Cash Flow Per Share | -1.54 | 0.91 | 1.85 | 1.20 | -2.43 |
Dividend Per Share | 0.200 | 1.500 | 0.700 | 0.370 | 0.316 |
Dividend Growth | -86.67% | 114.29% | 89.19% | 17.13% | -78.25% |
Gross Margin | 25.77% | 32.01% | 27.32% | 19.85% | 28.92% |
Operating Margin | 6.60% | 12.26% | 7.95% | 0.54% | 8.04% |
Profit Margin | 6.96% | 11.98% | 5.46% | 2.11% | 5.35% |
Free Cash Flow Margin | -11.36% | 6.26% | 11.60% | 7.81% | -13.65% |
EBITDA | 113.78 | 141.78 | 108 | 51.54 | 100.5 |
EBITDA Margin | 14.61% | 19.05% | 14.71% | 7.61% | 13.87% |
D&A For EBITDA | 62.36 | 50.54 | 49.64 | 47.89 | 42.25 |
EBIT | 51.42 | 91.24 | 58.36 | 3.65 | 58.24 |
EBIT Margin | 6.60% | 12.26% | 7.95% | 0.54% | 8.04% |
Effective Tax Rate | 24.16% | 17.00% | 26.11% | 20.62% | 37.98% |